Discover
IXHL
Incannex Healthcare Limited
3.21
1 x 3.16
3 x 3.52
bid
ask
+
0.00
0.00%
100 @ 04:00 PM
3.16 -0.05 (1.44%)
| Ytd | -70.11% | |
| 1y | -87.26% |
3.17
day range
3.25
2.49
52 week range
49.80
| Open | 3.21 | Prev Close | 3.21 | Low | 3.17 | High | 3.25 | Mkt Cap | 38.41M |
| Vol | 72.33K | Avg Vol | 296.37K | EPS | -0.69 | P/E | -4.69 | Forward P/E | -0.86 |
| Beta | 6.95 | Short Ratio | 1.76 | Inst. Own | 4.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 3.54 | 200-d Avg | 7.22 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 4.05M | ||
| Research and Development Expense | 321.00K | ||
| Selling, General and Administrative Expense | 3.73M | ||
| Operating Income | -4.05M | ||
| Net Income | -3.88M | ||
| Net Income Common Stock | -3.88M | ||
| Net Income Common Stock (USD) | -3.88M | ||
| Consolidated Income | -3.88M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -3.88M | ||
| Earning Before Interest & Taxes (USD) | -3.88M | ||
| Weighted Average Shares | 12.35M | ||
| Weighted Average Shares Diluted | 12.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 74.45M | ||
| Cash and Equivalents (USD) | 74.45M | ||
| Investments | 27.00K | ||
| Investments Non-Current | 27.00K | ||
| Current Assets | 80.10M | ||
| Property, Plant & Equipment Net | 161.00K | ||
| Total Assets | 80.28M | ||
| Debt Current | 72.00K | ||
| Total Debt | 114.00K | ||
| Current Liabilities | 1.93M | ||
| Debt Non-Current | 42.00K | ||
| Total Liabilities | 5.05M | ||
| Accumulated Retained Earnings (Deficit) | -174.37M | ||
| Accumulated Other Comprehensive Income | -3.66M | ||
| Shareholders Equity | 75.23M | ||
| Shareholders Equity (USD) | 75.23M | ||
| Assets Non-Current | 188.00K | ||
| Total Debt (USD) | 114.00K | ||
| Liabilities Non-Current | 3.12M | ||
| Trade and Non-Trade Payables | 1.63M | ||
| Tax Assets | 5.24M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 65.00K | ||
| Net Cash Flow from Financing | 4.71M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.24M | ||
| Capital Expenditure | -5.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -13.00K | ||
| Issuance (Purchase) of Equity Shares | 5.82M | ||
| Net Cash Flow from Investing | -18.00K | ||
| Net Cash Flow from Operations | -2.46M | ||
| Effect of Exchange Rate Changes on Cash | 3.02M | ||
| Share Based Compensation | 1.47M | ||